Browse Pet Safety Reports
969,382 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 969,382 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 969,382 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 11, 2026 | Dog | Papillon - Spaniel - Contin... | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Mar 11, 2026 | Dog | Poodle (unspecified), Dog (... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 11, 2026 | Dog | Bichon Frise, Dog (unknown) | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 11, 2026 | Dog | Crossbred Canine/dog | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 11, 2026 | Dog | Terrier - Bull - American Pit | Moxidectin | Lack of efficacy (endoparasite) - tapeworm; Medication error NOS | Ongoing |
| Mar 11, 2026 | Dog | Chihuahua | Fluralaner 13.64% 12-Week Chew | Itching; Rash; Hives (see also Skin); Hypersensitivity reaction; Administrati... | Ongoing |
| Mar 11, 2026 | Dog | Shepherd Dog - Australian | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Mar 11, 2026 | Dog | Crossbred Canine/dog | Selamectin | Lack of efficacy (ectoparasite) - tick NOS | Outcome Unknown |
| Mar 11, 2026 | Dog | Crossbred Canine/dog | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 11, 2026 | Dog | Terrier - Bull - American Pit | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 11, 2026 | Dog | Corgi - Welsh Pembroke | Bedinvetmab | Increased appetite | Outcome Unknown |
| Mar 11, 2026 | Dog | Crossbred Canine/dog | Lotilaner,Moxidectin,Praziquantel,Pyr... | Vomiting; Pale mucous membrane; Hypersalivation; Behavioural disorder NOS; Ot... | Outcome Unknown |
| Mar 11, 2026 | Dog | Terrier - Yorkshire | Milbemycin/Lufenuron/Pzq Chew | Vomiting | Recovered/Normal |
| Mar 11, 2026 | Dog | Terrier - Yorkshire, Dog (u... | Moxidectin | Lack of efficacy (endoparasite) - hookworm; Lack of efficacy (protozoa) - Coc... | Ongoing |
| Mar 11, 2026 | Dog | Poodle - Miniature | Moxidectin | Allergic reaction | Outcome Unknown |
| Mar 11, 2026 | Dog | Dog (unknown) | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Mar 11, 2026 | Dog | Crossbred Canine/dog, Spani... | Fluralaner Powder For Inj Susp | Vomiting bile; Listless; Pale mucous membrane; Laboured breathing; Bradypnoea... | Recovered/Normal |
| Mar 11, 2026 | Dog | Chihuahua | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm; Drug dose administration interval... | Ongoing |
| Mar 11, 2026 | Dog | Retriever - Golden, Poodle ... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 11, 2026 | Dog | Cattle Dog - Australian (bl... | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Mar 11, 2026 | Dog | Retriever - Golden | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 11, 2026 | Dog | Shepherd Dog - Australian | Milbemycin/Lufenuron/Pzq Chew | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 11, 2026 | Dog | Spaniel (unspecified), Pood... | Moxidectin | Emesis (multiple); Listless; Pale mucous membrane; Bradypnoea; Laboured breat... | Recovered/Normal |
| Mar 11, 2026 | Dog | Poodle - Standard | Maropitant Citrate | Administration error NOS; Injection site bruising; Injection site blister | Ongoing |
| Mar 11, 2026 | Dog | Retriever - Labrador, Dog (... | Oclacitinib Maleate | Vomiting; Intentional misuse | Outcome Unknown |
| Mar 11, 2026 | Dog | Retriever - Labrador | Moxidectin | Lack of efficacy (endoparasite) - hookworm; Weight gain | Ongoing |
| Mar 11, 2026 | Dog | Retriever - Golden, Poodle ... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 11, 2026 | Dog | Dalmatian, Crossbred Canine... | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - whipworm | Outcome Unknown |
| Mar 11, 2026 | Dog | Dog (unknown) | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Behavi... | Outcome Unknown |
| Mar 10, 2026 | Dog | Shih Tzu | Milbemycin/Lufenuron/Pzq Chew | Blood in vomit; Not eating; Not drinking | Ongoing |
| Mar 10, 2026 | Dog | Collie - Border | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - tapeworm | Outcome Unknown |
| Mar 10, 2026 | Dog | Poodle - Toy | Pyrantel Pamoate;Sarolaner | Rolling; Neurological signs NOS; Vomiting; Collapse NOS (see also Cardio-vasc... | Ongoing |
| Mar 10, 2026 | Dog | Portuguese Water Dog | Oclacitinib Maleate | Panting | Ongoing |
| Mar 10, 2026 | Dog | Shepherd Dog - Belgian Mali... | Milbemycin/Lufenuron/Pzq Chew | Shaking; Fasciculation; Ataxia | Recovered/Normal |
| Mar 10, 2026 | Dog | Retriever - Labrador | Spinosad; Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm; Drug dose omission | Outcome Unknown |
| Mar 10, 2026 | Dog | Crossbred Canine/dog | Insulin Injectable Vial | Lack of efficacy - NOS | Recovered/Normal |
| Mar 10, 2026 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 10, 2026 | Dog | Pit Bull | Afoxolaner | Seizure NOS; Apnoea; Hypothermia; Hypoglycaemia; Elevated haematocrit; Death ... | Euthanized |
| Mar 10, 2026 | Dog | Terrier (unspecified) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Mar 10, 2026 | Dog | Bulldog - French | Fluralaner Powder For Inj Susp | Hives (see also Skin); Generalised itching; Hypersensitivity reaction | Recovered/Normal |
| Mar 10, 2026 | Dog | Crossbred Canine/dog | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 10, 2026 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Powder For Inj Susp | Emesis (multiple) | Outcome Unknown |
| Mar 10, 2026 | Dog | Maltese | Fluralaner Powder For Inj Susp | Emesis (multiple) | Outcome Unknown |
| Mar 10, 2026 | Dog | Rottweiler | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 10, 2026 | Dog | Bulldog - French | Fluralaner Powder For Inj Susp | Generalised itching; Hives (see also Skin); Vomiting; Swelling NOS; Hypersens... | Outcome Unknown |
| Mar 10, 2026 | Dog | Boxer (German Boxer), Retri... | Moxidectin | Emesis (multiple); Facial swelling (see also Skin); Lethargy (see also Centra... | Ongoing |
| Mar 10, 2026 | Dog | Retriever (unspecified), Do... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm; Lack of efficacy (bacteria) - Eh... | Ongoing |
| Mar 10, 2026 | Dog | Retriever - Golden | Oclacitinib Maleate | Vomiting | Outcome Unknown |
| Mar 10, 2026 | Dog | Great Pyrenees | Oclacitinib Maleate | Bacterial skin infection NOS; Abnormal cytology; Other abnormal test result N... | Ongoing |
| Mar 10, 2026 | Dog | Retriever - Labrador, Dog (... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.